ECM
MNTA

ETrade Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

ETrade Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,042
Closed -$201K – 969
2020
Q2 		$201K Buy
+6,042
New +$192K ﹤0.01% 790

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ETrade Capital Management's MNTA Position: Q3 2020 in Review

ETrade Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 6,042 shares — an estimated $201K sold.

ETrade Capital Management first reported a position in MNTA in Q2 2020 and held it in 1 quarter. The position peaked at $201K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • ETrade Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • ETrade Capital Management sold 6,042 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $201K.
  • ETrade Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • ETrade Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $201K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.